VNRX

VolitionRx Limited

0.25

USD

0.00

-0.49%

Sep 24, 15:37 UTC -4

Closed

Pre-Market

0.25

0.00

+0.08%

VolitionRx Limited Profile

About

Volition RX Ltd is a life sciences company engaged in developing a range of blood-based epigenetic cancer diagnostic tests. Its tests are designed to detect the nucleosome patterns that are specific to cancer in the blood, and identify some of the major nucleosome varieties that differ between cancer types. The Company's development activities are primarily centered in Belgium. Volition RX Ltd is based in Singapore.

Info & Links

CEO

Cameron Reynolds

Headquarters

1489 WEST WARM SPRINGS ROAD, SUITE 110
HENDERSON, NV 89014, UNITED STATES

Auditor

Sadler, Gibb & Associates, LLC

Share holders

173

Employees

VolitionRx Limited Statistics

Valuation Measures

Market Capitalization²

6.86M

Enterprise Value

15.12M

Enterprise Value/EBITDA(ttm)

-0.94

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.46

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-948.05%

Profit Margin(ttm)

-1193.61%

Return on Equity(ttm)

Return on Invested Capital(ttm)

94.38%

Return on Assets(ttm)

-303.75%

Income Statement

Revenue(ttm)

2.46M

Revenue Per Share(ttm)

0.18

Gross Profit(ttm)

2.46M

EBITDA(ttm)³

-16.06M

Net Income Available to Common(ttm)

-25.64M

Diluted EPS(ttm)

-3.82

Share Statistics

Beta (5Y Monthly)

1.10

52-Week Change

-97.97%

S&P 500 52-Week Change

19.38%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

13.65M

Dividend Yield

0.00%

Float⁴

12.71M

% Held by Insiders

6.90%

% Held by Institutions

8.09%

Balance Sheet

Total Cash(mrq)

2.79M

Total Cash Per Share(mrq)

0.20

Total Debt(mrq)

11.05M

Total Debt/Equity(mrq)

-32.94%

Current Ratio(mrq)

0.30%

Quick Ratio(mrq)

0.30%

Book Value Per Share(mrq)

-2.78

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.14

Free Cash Flow(ytd)

-10.45M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.